Publication | Closed Access

Neuroprotective effects of bergenin in Alzheimer’s disease: Investigation through molecular docking, in vitro and in vivo studies

Neurodegenerative DiseasesAlzheimer's DiseaseVivo StudiesMedicinePharmacologyNeuropharmacologyDegenerative PathologyNeuroprotectionNeurologyNeuroscienceNeurodegenerationMolecular DockingNeuroprotective EffectsProtective MechanismsNeuroinflammation